Alemayehu Godana Birhanu

Dr. Alemayehu Godana Birhanu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 August 2023 in Clinical Proteomics
Verified
Journal Article
Open access
PDF file
ABAlemayehu Godana Birhanu
Alemayehu Godana Birhanu
Mass spectrometry (MS)-based proteomics have been increasingly implemented in various disciplines of laboratory medicine to identify and quantify biomolecules in a variety of biological specimens. MS-based proteomics is continuously expanding and widely applied in biomarker discovery for early detection, prognosis and markers for treatment response prediction and monitoring. Furthermore, making these advanced tests more accessible and affordable will have the greatest healthcare benefit.This review article highlights the new paradigms MS-based clinical proteomics has created in microbiology laboratories, cancer research and diagnosis of metabolic disorders. The technique is preferred over conventional methods in disease detection and therapy monitoring for its combined advantages in multiplexing capacity, remarkable analytical specificity and sensitivity and low turnaround time.Despite the achievements in the development and adoption of a number of MS-based clinical proteomics practices, more are expected to undergo transition from bench to bedside in the near future. The review provides insights from early trials and recent progresses (mainly covering literature from the NCBI database) in the application of proteomics in clinical laboratories.

27 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABAlemayehu Godana Birhanu
Alemayehu Godana Birhanu
SYSolomon Abebe Yimer
Solomon Abebe Yimer
Shewit KalayouShewit Kalayou
Shewit Kalayou
TRTahira Riaz
Tahira Riaz
EZEphrem Debebe Zegeye
Ephrem Debebe Zegeye
TTTone Tonjum
Tone Tonjum
Multiple regulatory mechanisms including post-translational modifications (PTMs) confer complexity to the simpler genomes and proteomes of Mycobacterium tuberculosis (Mtb). PTMs such as glycosylation play a significant role in Mtb adaptive processes. The glycoproteomic patterns of clinical isolates of the Mycobacterium tuberculosis complex (MTBC) representing the lineages 3, 4, 5 and 7 were characterized by mass spectrometry. A total of 2944 glycosylation events were discovered in 1325 proteins. This data set represents the highest number of glycosylated proteins identified in Mtb to date. O-glycosylation constituted 83% of the events identified, while 17% of the sites were N-glycosylated. This is the first report on N-linked protein glycosylation in Mtb and in Gram-positive bacteria. Collectively, the bulk of Mtb glycoproteins are involved in cell envelope biosynthesis, fatty acid and lipid metabolism, two-component systems, and pathogen-host interaction that are either surface exposed or located in the cell wall. Quantitative glycoproteomic analysis revealed that 101 sites on 67 proteins involved in Mtb fitness and survival were differentially glycosylated between the four lineages, among which 64% were cell envelope and membrane proteins. The differential glycosylation pattern may contribute to phenotypic variabilities across Mtb lineages. The study identified several clinically important membrane-associated glycolipoproteins that are relevant for diagnostics as well as for drug and vaccine discovery.

1 January 2025 in Environmental Health Insights
Verified
Journal Article
Open access
TATesfaye Admassu Abate
Tesfaye Admassu Abate
ABAlemayehu Godana Birhanu
Alemayehu Godana Birhanu
Antimicrobial use in animal husbandry is a common practice in developing countries as a response to the growing demand for animal-based foods. Veterinary antibiotics account for most of the antibiotics used worldwide. This review aims to provide an overview of the impact of antibiotic usage in livestock production on the environment and its consequences in the emergence and spread of antibiotic resistance. The global estimate of antibiotic consumption in animals ranges from 63 000 to 106 000 tons annually. The most commonly used antibiotic classes include tetracyclines, sulfonamides, β-lactams, macrolides, and trimethoprim. Most of the antibiotics used in animal treatments are not fully metabolized within the animal’s body; instead, they are excreted and can enter the environment. This review also provides a brief overview of the fate of antibiotic residues and their behavior in the environment. In developing countries, in addition to the lack of data on antibiotic use trends, there are limitations in implementing scientific and regulatory frameworks for antibiotic use in livestock. To reduce the projected loss of lives associated with antimicrobial resistant infections, it is recommended to lower antibiotic contamination in the environment by implementing affordable and critical actions related to antibiotic usage and residual waste management. Actions such as rational use of antibiotics in all circumstances, reducing environmental exposure to antibiotics, research, and environmental surveillance are important to tackle the problems of antibiotic resistance, especially in low-income countries.

4 October 2017 in Journal of Proteome Research
Verified
Journal Article
Closed access
ABAlemayehu Godana Birhanu
Alemayehu Godana Birhanu
SYSolomon Abebe Yimer
Solomon Abebe Yimer
CHCarol Holm-Hansen
Carol Holm-Hansen
GNGunnstein Norheim
Gunnstein Norheim
AAAbraham Aseffa
Abraham Aseffa
TTTone Tonjum
Tone Tonjum

9 May 2017 in Frontiers in Microbiology
Verified
Journal Article
Open access
SYSolomon A. Yimer
Solomon A. Yimer
ABAlemayehu Godana Birhanu
Alemayehu Godana Birhanu
Shewit KalayouShewit Kalayou
Shewit Kalayou
TRTahira Riaz
Tahira Riaz
EZEphrem D. Zegeye
Ephrem D. Zegeye
TTTone Tønjum
Tone Tønjum
In order to decipher the nature of the slowly growing Mycobacterium tuberculosis (M. tuberculosis) lineage 7, the differentially abundant proteins in strains of M. tuberculosis lineage 7 and lineage 4 were defined. Comparative proteomic analysis by mass spectrometry was employed to identify, quantitate and compare the protein profiles of strains from the two M. tuberculosis lineages. Label-free peptide quantification of whole cells from M. tuberculosis lineage 7 and 4 yielded the identification of 2825 and 2541 proteins, respectively. A combined total of 2867 protein groups covering 71% of the predicted M. tuberculosis proteome were identified. The abundance of 125 proteins in M. tuberculosis lineage 7 and 4 strains was significantly altered. Notably, the analysis showed that a number of M. tuberculosis proteins involved in growth and virulence were less abundant in lineage 7 strains compared to lineage 4. Five ABC transporter proteins, three phosphate binding proteins essential for inorganic phosphate uptake, and six components of the type 7 secretion system ESX-3 involved in iron acquisition were less abundant in M. tuberculosis lineage 7. This proteogenomic analysis provided an insight into the lineage 7-specific protein profile which may provide clues to understanding the differential properties of lineage 7 strains in terms of slow growth, survival fitness and pathogenesis.

14 January 2022 in ACS Omega
Verified
Journal Article
Open access
ABAlemayehu Godana Birhanu
Alemayehu Godana Birhanu
MGMarta Gómez-Muñoz
Marta Gómez-Muñoz
Shewit KalayouShewit Kalayou
Shewit Kalayou
TRTahira Riaz
Tahira Riaz
TLTimo Lutter
Timo Lutter
TTTone Tonjum
Tone Tonjum
Reactive nitrogen species (RNS) are secreted by human cells in response to infection by Mycobacterium tuberculosis (Mtb). Although RNS can kill Mtb under some circumstances, Mtb can adapt and survive in the presence of RNS by a process that involves modulation of gene expression. Previous studies focused primarily on stress-related changes in the Mtb transcriptome. This study unveils changes in the Mtb proteome in response to a sub-lethal dose of nitric oxide (NO) over several hours of exposure. Proteins were identified using liquid chromatography coupled with electrospray ionization mass spectrometry (LC–MS/MS). A total of 2911 Mtb proteins were identified, of which 581 were differentially abundant (DA) after exposure to NO in at least one of the four time points (30 min, 2 h, 6 h, and 20 h). The proteomic response to NO was marked by two phases, with few DA proteins in the early phase and a multitude of DA proteins in the later phase. The efflux pump Rv1687 stood out as being the only protein more abundant at all the time points and might play a role in the early protection of Mtb against nitrosative stress. These changes appeared to be compensatory in nature, contributing to iron homeostasis, energy metabolism, and other stress responses. This study thereby provides new insights into the response of Mtb to NO at the level of proteomics.